Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inactive serine protease 54 (PRSS54) is a testis-specific protein in humans and mice, encoded by the PRSS54 gene. Although structurally related to serine-type endopeptidases (S1 peptidase domain), it is considered catalytically inactive. PRSS54 localizes to the acrosomal granule and inner acrosomal membrane during spermatogenesis, and is implicated in acrosome biogenesis and sperm head morphogenesis, as knockout mice exhibit acrosomal and sperm structure defects leading to subfertility[1]. Expression is restricted to testis under normal conditions, but PRSS54 (as a cancer/testis antigen, CT67) may be epigenetically reactivated in cancers, and thus could serve as a biomarker for certain malignancies or in reproductive biology[4][5]. Alternative splicing produces multiple transcript variants[5]. No direct pharmacological targeting of PRSS54 with drugs is reported, but its high specificity to testis and immunogenic potential in cancer warrant further research in biomarker and immunotherapy contexts[4].
No known active mechanism for drug targeting; putative function as an antigenic biomarker or indirect testis/cancer-related target[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inactive serine protease 54 (PRSS54).